Tongyao Liu

Person

Alameda, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Nucleic acid molecules and uses thereof for non-viral gene therapy
- Patent number 12,364,774
- Issue date Jul 22, 2025
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor IX gene
- Patent number 12,275,970
- Issue date Apr 15, 2025
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for the purification of viral vectors
- Patent number 12,173,307
- Issue date Dec 24, 2024
- Bioverativ Therapeutics Inc.
- Mukesh Mayani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Nucleic acid molecules and uses thereof
- Patent number 12,168,776
- Issue date Dec 17, 2024
- Bioverativ Therapeutics Inc.
- Alexey Seregin
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Optimized factor VIII genes
- Patent number 11,753,461
- Issue date Sep 12, 2023
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Chimeric factor VIII polypeptides and uses thereof
- Patent number 11,370,827
- Issue date Jun 28, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of reducing immunogenicity against factor VIII in individua...
- Patent number 11,286,528
- Issue date Mar 29, 2022
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII chimeric proteins and uses thereof
- Patent number 11,192,936
- Issue date Dec 7, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Factor VIII complex with XTEN and von Willebrand Factor protein, an...
- Patent number 11,091,534
- Issue date Aug 17, 2021
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized factor IX gene
- Patent number 11,008,561
- Issue date May 18, 2021
- Bioverativ Therapeutics Inc.
- Siyuan Tan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor IX fusion proteins and methods of making and using same
- Patent number 10,745,680
- Issue date Aug 18, 2020
- Bioverativ Therapeutics Inc.
- Zhiqian Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII-XTEN fusions and uses thereof
- Patent number 10,548,953
- Issue date Feb 4, 2020
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Factor VIII compositions and methods of making and using same
- Patent number 10,421,798
- Issue date Sep 24, 2019
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of reducing immunogenicity against factor VIII in individua...
- Patent number 10,221,455
- Issue date Mar 5, 2019
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Factor VIII complex with XTEN and von Willebrand Factor protein, an...
- Patent number 10,138,291
- Issue date Nov 27, 2018
- Bioverativ Therapeutics Inc.
- Ekta Seth Chhabra
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR THE PURIFICATION OF VIRAL VECTORS
- Publication number 20250179523
- Publication date Jun 5, 2025
- Bioverativ Therapeutics Inc.
- Mukesh Mayani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACID MOLECULES AND USES THEREOF
- Publication number 20250171805
- Publication date May 29, 2025
- Bioverativ Therapeutics Inc.
- Alexey SEREGIN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED FACTOR IX GENE
- Publication number 20250154489
- Publication date May 15, 2025
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
NUCLEIC ACIDS ENCODING FACTOR VIII POLYPEPTIDES WITH REDUCED IMMUNO...
- Publication number 20240350672
- Publication date Oct 24, 2024
- Bioverativ Therapeutics Inc.
- Tongyao LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BACULOVIRUS EXPRESSION SYSTEM
- Publication number 20240294940
- Publication date Sep 5, 2024
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED FACTOR VIII GENES
- Publication number 20240124555
- Publication date Apr 18, 2024
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF
- Publication number 20240083975
- Publication date Mar 14, 2024
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230322900
- Publication date Oct 12, 2023
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES
- Publication number 20230091932
- Publication date Mar 23, 2023
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED FACTOR VIII GENES
- Publication number 20230084036
- Publication date Mar 16, 2023
- Bioverativ Therapeutics Inc.
- Ajay Maghodia
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20230019286
- Publication date Jan 19, 2023
- Bioverativ Therapeutics Inc.
- Volker SCHELLENBERGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF
- Publication number 20230011438
- Publication date Jan 12, 2023
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...
- Publication number 20230002828
- Publication date Jan 5, 2023
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BACULOVIRUS EXPRESSION SYSTEM
- Publication number 20220356490
- Publication date Nov 10, 2022
- Bioverativ Therapeutics Inc.
- Tongyao Liu
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF
- Publication number 20220275057
- Publication date Sep 1, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF
- Publication number 20220106383
- Publication date Apr 7, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...
- Publication number 20220056108
- Publication date Feb 24, 2022
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR THE PURIFICATION OF VIRAL VECTORS
- Publication number 20220033849
- Publication date Feb 3, 2022
- Bioverativ Therapeutics Inc.
- Mukesh Mayani
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210238259
- Publication date Aug 5, 2021
- Bioverativ Therapeutics Inc.
- Arjan VAN DER FLIER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULES AND USES THEREOF
- Publication number 20210163986
- Publication date Jun 3, 2021
- Bioverativ Therapeutics Inc.
- Alexey SEREGIN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED FACTOR IX GENE
- Publication number 20210115425
- Publication date Apr 22, 2021
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII
- Publication number 20210038744
- Publication date Feb 11, 2021
- BIOVERATIV THERAPEUTICS INC.
- Andrea ANNONI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME
- Publication number 20210032616
- Publication date Feb 4, 2021
- Bioverativ Therapeutics Inc.
- Zhiqian LIU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR IX
- Publication number 20200199626
- Publication date Jun 25, 2020
- Bioverativ Therapeutics Inc.
- Tongyao LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20200087379
- Publication date Mar 19, 2020
- Bioverativ Therapeutics Inc.
- Volker Schellenberger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY
- Publication number 20200069817
- Publication date Mar 5, 2020
- Bioverativ Therapeutics Inc.
- Tongyao LIU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME
- Publication number 20190315835
- Publication date Oct 17, 2019
- Bioverativ Therapeutics Inc.
- Volker SCHELLENBERGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...
- Publication number 20190241960
- Publication date Aug 8, 2019
- Bioverativ Therapeutics Inc.
- Haiyan Jiang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OPTIMIZED FACTOR VIII GENES
- Publication number 20190185543
- Publication date Jun 20, 2019
- Bioverativ Therapeutics Inc.
- Siyuan TAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...
- Publication number 20190169267
- Publication date Jun 6, 2019
- Bioverativ Therapeutics Inc.
- Ekta Seth CHHABRA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Tongyao Liu

Person

Patents Grantslast 30 patents

Nucleic acid molecules and uses thereof for non-viral gene therapy

Optimized factor IX gene

Methods for the purification of viral vectors

Nucleic acid molecules and uses thereof

Optimized factor VIII genes

Chimeric factor VIII polypeptides and uses thereof

Methods of reducing immunogenicity against factor VIII in individua...

Factor VIII chimeric proteins and uses thereof

Factor VIII complex with XTEN and von Willebrand Factor protein, an...

Optimized factor IX gene

Factor IX fusion proteins and methods of making and using same

Factor VIII-XTEN fusions and uses thereof

Factor VIII compositions and methods of making and using same

Methods of reducing immunogenicity against factor VIII in individua...

Factor VIII complex with XTEN and von Willebrand Factor protein, an...

Patents Applicationslast 30 patents

METHODS FOR THE PURIFICATION OF VIRAL VECTORS

NUCLEIC ACID MOLECULES AND USES THEREOF

OPTIMIZED FACTOR IX GENE

NUCLEIC ACIDS ENCODING FACTOR VIII POLYPEPTIDES WITH REDUCED IMMUNO...

BACULOVIRUS EXPRESSION SYSTEM

OPTIMIZED FACTOR VIII GENES

THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

CLOSED-END DNA PRODUCTION WITH INVERTED TERMINAL REPEAT SEQUENCES

OPTIMIZED FACTOR VIII GENES

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

CHIMERIC FACTOR VIII POLYPEPTIDES AND USES THEREOF

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...

BACULOVIRUS EXPRESSION SYSTEM

FACTOR VIII CHIMERIC PROTEINS AND USES THEREOF

THROMBIN CLEAVABLE LINKER WITH XTEN AND ITS USES THEREOF

FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...

METHODS FOR THE PURIFICATION OF VIRAL VECTORS

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

NUCLEIC ACID MOLECULES AND USES THEREOF

OPTIMIZED FACTOR IX GENE

USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR VIII

FACTOR IX FUSION PROTEINS AND METHODS OF MAKING AND USING SAME

USE OF LENTIVIRAL VECTORS EXPRESSING FACTOR IX

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

NUCLEIC ACID MOLECULES AND USES THEREOF FOR NON-VIRAL GENE THERAPY

FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME

METHODS OF REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUA...

OPTIMIZED FACTOR VIII GENES

FACTOR VIII COMPLEX WITH XTEN AND VON WILLEBRAND FACTOR PROTEIN, AN...